Quantcast

Cu(II)-Doped Polydopamine-Coated Gold Nanorods for Tumor Theranostics

Research paper by Shuwei Liu, Lu Wang, Min Lin, Dandan Wang, Ziqi Song, Shuyao Li, Rui Ge, Xue Zhang, Yi Liu, Zhimin Li, Hongchen Sun, Bai Yang, Hao Zhang

Indexed on: 14 Dec '17Published on: 13 Dec '17Published in: ACS Applied Materials & Interfaces



Abstract

Gold nanorods (AuNRs) are potentially useful in tumor theranostics, but the poor stability, high toxicity, and rapid removal by the immune system seriously limit their theranostic applications. In our study, we demonstrate the fabrication of Cu(II)-doped polydopamine-coated AuNR (AuNR@CuPDA), which significantly improves the potentials in tumor theranostics. Besides the improvement of physiological stability and biocompatibility, the PDA shell increases the photothermal performance and prolongs the blood circulation time of AuNRs. The half-life of AuNRs during blood circulation increases from 0.7 to 4.5 h after PDA coating, and the injected dose per gram of tumor tissue is 4.6% ID g–1 for AuNR@CuPDA. In addition to computer tomography imaging, the loading of Cu(II) in PDA shell endows AuNR@CuPDA with magnetic resonance imaging function. Cu(II) doped in PDA shell also exhibits chemotherapeutic behavior, and the tumor inhibitor rate is 31.2%. Further combining 808 nm laser-driven photothermal therapy, tumors were completely ablated, and no recurrence was observed. Liver and renal functions tests and histological analysis of major organs confirm that AuNR@CuPDA is in good safety.

Figure 10.1021/acsami.7b13643.1.jpg
Figure 10.1021/acsami.7b13643.2.jpg
Figure 10.1021/acsami.7b13643.3.jpg
Figure 10.1021/acsami.7b13643.4.jpg
Figure 10.1021/acsami.7b13643.5.jpg
Figure 10.1021/acsami.7b13643.6.jpg
Figure 10.1021/acsami.7b13643.7.jpg
Figure 10.1021/acsami.7b13643.8.jpg
Figure 10.1021/acsami.7b13643.9.jpg
Figure 10.1021/acsami.7b13643.10.jpg